Arkolith/Insider Trading/DNMR/Form 4/A

Croskrey Stephen

CEO & Chairman of the Board, DirectorDanimer Scientific, Inc. (DNMR) · full profile →Form 4/A · filed Mar 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 28, 2023Grant(A)750K—$0750K
Feb 28, 2023Grant(A)300K—$0300K
Feb 28, 2023Grant(A)385K—$0385K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-23-021895) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML